HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients

NCT04986176 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

602

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Respiratory Infection

Interventions

DRUG: HC-1119
DRUG: Placebo

Sponsor

Applied Biology, Inc.

Collaborators

[object Object]